Business
Moderna CEO sees virus vaccine interim data in November: Report – Aljazeera.com
US drugmaker’s CEO says Washington could approve vaccine for emergency use in December, Wall Street Journal reports.
Moderna Incs Chief Executive Officer Stephane Bancel expects interim results from its coronavirus vaccine trial in November and that the United States government could approve the drug for emergency use in December, the Wall Street Journal newspaper reported.
Speaking at the newspapers annual Tech Live conference, Bancel also said on Monday that if sufficient interim results from the study are delayed, government permission to use the vaccine may not come until next year.
The first interim ana…
-
General22 hours agoCampers evacuated, residents on alert as Moreton Island bushfire intensifies
-
General19 hours agoHundreds attend justice march for Kaiden Morgan-Johnston in Morwell
-
Noosa News20 hours agoHow Roosters star Eliza Lopamaua found her way to NRLW
-
Noosa News22 hours agoATO investigator found to have lied in fraud case